TY - JOUR
T1 - Impact of obesity on robotic-assisted surgery in patients with stage IA endometrial cancer and a low risk of recurrence
T2 - An institutional study
AU - Asanoma, Kazuo
AU - Yahata, Hideaki
AU - Kaoru, Okugawa
AU - Ohgami, Tatsuhiro
AU - Yasunaga, Masafumi
AU - Kodama, Keisuke
AU - Onoyama, Ichiro
AU - Kenjo, Hironori
AU - Shimokawa, Mototsugu
AU - Kato, Kiyoko
N1 - Funding Information:
This work was supported by JSPS KAKENHI grant numbers JP22K19604 (to Kiyoko Kato) and JP21K09519 (to Kazuo Asanoma).
Publisher Copyright:
© 2022 Japan Society of Obstetrics and Gynecology.
PY - 2022
Y1 - 2022
N2 - Aim: Westernization of lifestyle has increased the numbers of patients with endometrial cancer and obesity. This study aimed to compare the clinical outcomes of robotic-assisted surgery according to whether patients are obese, morbidly obese, or nonobese. Methods: Sixty-three patients with endometrial cancer who underwent robotic-assisted surgery between March 2014 and June 2022 were categorized according to whether they had a body mass index (BMI) <30 (group A, nonobese, n = 40), ≥30 and <35 (group B, obese, n = 13), or ≥35 (group C, morbidly obese, n = 10). Operation time, blood loss, perioperative complications, and recurrence rate were investigated. Results: Conversion to laparotomy was required in one case in group A and one in group C. There was no difference in total operation time, time for setting (including trocar installation and docking of the da Vinci robot), console time, or time for wound closure between the groups; however, there was a significant between-group difference in the total time for setting and wound closure. There was no significant difference in blood loss or complications between the groups. Three patients in group A and two in group B received adjuvant treatment; none have shown evidence of recurrent disease during a mean observation time of 21 months (range, 2–29). Two cases in group A and one in group B had recurrence during a mean observation time of 38 months (range, 19–46). Conclusion: Patients with endometrial cancer who are obese can be treated safely by robotic-assisted surgery with a low risk of complications and few relapses.
AB - Aim: Westernization of lifestyle has increased the numbers of patients with endometrial cancer and obesity. This study aimed to compare the clinical outcomes of robotic-assisted surgery according to whether patients are obese, morbidly obese, or nonobese. Methods: Sixty-three patients with endometrial cancer who underwent robotic-assisted surgery between March 2014 and June 2022 were categorized according to whether they had a body mass index (BMI) <30 (group A, nonobese, n = 40), ≥30 and <35 (group B, obese, n = 13), or ≥35 (group C, morbidly obese, n = 10). Operation time, blood loss, perioperative complications, and recurrence rate were investigated. Results: Conversion to laparotomy was required in one case in group A and one in group C. There was no difference in total operation time, time for setting (including trocar installation and docking of the da Vinci robot), console time, or time for wound closure between the groups; however, there was a significant between-group difference in the total time for setting and wound closure. There was no significant difference in blood loss or complications between the groups. Three patients in group A and two in group B received adjuvant treatment; none have shown evidence of recurrent disease during a mean observation time of 21 months (range, 2–29). Two cases in group A and one in group B had recurrence during a mean observation time of 38 months (range, 19–46). Conclusion: Patients with endometrial cancer who are obese can be treated safely by robotic-assisted surgery with a low risk of complications and few relapses.
UR - http://www.scopus.com/inward/record.url?scp=85137987311&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137987311&partnerID=8YFLogxK
U2 - 10.1111/jog.15434
DO - 10.1111/jog.15434
M3 - Article
C2 - 36110050
AN - SCOPUS:85137987311
SN - 1341-8076
JO - Journal of Obstetrics and Gynaecology Research
JF - Journal of Obstetrics and Gynaecology Research
ER -
